ALYREF and breast cancer: Using a breast cancer screening cohort (n = 128) (Table S1), we identified high levels of intra-tumoral ALYREF mRNA expression as significantly associated with poor disease-free survival (p = 0.041, log-rank test, Fig. 1D) and poor overall survival (p = 0.009, log-rank test, Fig. 1E).